Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Ontrak, Inc. (OTRK)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
5.49-0.73 (-11.74%)
At close: 04:00PM EST
5.56 +0.07 (+1.28%)
After hours: 07:57PM EST
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Relative Strength Index (RSI)

Relative Strength Index (RSI)

Previous Close6.22
Open6.17
Bid5.48 x 1300
Ask5.60 x 1000
Day's Range5.41 - 6.17
52 Week Range5.41 - 99.89
Volume525,340
Avg. Volume1,188,585
Market Cap105.215M
Beta (5Y Monthly)2.00
PE Ratio (TTM)N/A
EPS (TTM)-1.58
Earnings DateNov 04, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est17.80
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for OTRK

Learn more
View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Ontrak, Inc.
    Analyst Report: Centene CorporationCentene is a managed-care organization focused on government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges. After acquiring WellCare in early 2020, Centene served 22 million medical members as of September 2021, mostly in Medicaid (68% of membership), the individual exchanges (10%), Medicare Advantage (6%), and the balance in Tricare (West region), correctional facility, and international plans. The company also serves 4 million users through the Medicare Part D pharmaceutical program.
    Rating
    Fair Value
    Economic Moat
    4 days agoMorningstar
View more
Advertisement
Advertisement